David W Haas (David Haas)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Cerebrospinal Fluid

Antiretroviral Therapy

Natural Killer Cells

Monoclonal Antibody

Top Venues

Science (New York, N.Y.)

British journal of clinical pharmacology

Southern African journal of HIV medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Mathias Viard, Colm O'hUigin, Yuko Yuki, Arman A Bashirova, David R Collins, Jonathan M Urbach, Steven M Wolinsky, Susan P Buchbinder, Gregory D Kirk, James J Goedert, Nelson L Michael, David W Haas, Steven G Deeks, Bruce D Walker, Xu G Yu, Mary N Carrington
Impact of HLA class I functional divergence on HIV control. Science (New York, N.Y.) 383 (6680) (2024)
Eric H Decloedt, Phumla Z Sinxadi, Lubbe Wiesner, John A Joska, David W Haas, Gary Maartens
Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid. Southern African journal of HIV medicine 22 (1) (2021)
Hector F Myers, Alecia M Fair, Fernando Villalta, Katherina Walz, Bettina M Beech, William K Scott, David W Haas
Transdisciplinary Perspectives on Precision Medicine. Health equity 5 (1) (2021)
Veron Ramsuran, Vivek Naranbhai, Amir Horowitz, Ying Qi, Maureen P Martin, Yuko Yuki, Xiaojiang Gao, Victoria E K Walker-Sperling, Gregory Q Del Prete, Douglas K Schneider, Jeffrey D Lifson, Jacques Fellay, Steven G Deeks, Jeffrey N Martin, James J Goedert, Steven M Wolinsky, Nelson L Michael, Gregory D Kirk, Susan Buchbinder, David W Haas, Thumbi Ndung'u, Philip J R Goulder, Peter Parham, Bruce D Walker, Jonathan M Carlson, Mary N Carrington
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science (New York, N.Y.) 359 (6371) (2018)